These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Safety of selegiline (deprenyl) in the treatment of Parkinson's disease. Heinonen EH; Myllylä V Drug Saf; 1998 Jul; 19(1):11-22. PubMed ID: 9673855 [TBL] [Abstract][Full Text] [Related]
23. Strategies in the treatment of early Parkinson's disease. Rinne UK Acta Neurol Scand Suppl; 1993; 146():50-3. PubMed ID: 8101417 [TBL] [Abstract][Full Text] [Related]
25. [Dyskinesia in Parkinson's disease: an update on new neuroimaging methods and treatment possibilities]. Thomsen BL; Herz DM; Siebner HR; Løkkegaard A Ugeskr Laeger; 2017 Mar; 179(10):. PubMed ID: 28263159 [TBL] [Abstract][Full Text] [Related]
26. [Stage-adjusted treatment of idiopathic Parkinson syndrome]. Ludin HP Wien Med Wochenschr; 1995; 145(13):294-8. PubMed ID: 7571654 [TBL] [Abstract][Full Text] [Related]
27. [Optimization of the treatment of Parkinson's disease using dopamine agonists]. Rinne UK Arch Neurobiol (Madr); 1991; 54(6):282-7. PubMed ID: 1687430 [No Abstract] [Full Text] [Related]
32. [Current treatment strategies for Parkinson's disease]. Südmeyer M; Wojtecki L; Schnitzler A Fortschr Neurol Psychiatr; 2011 Dec; 79(12):733-43. PubMed ID: 22161168 [No Abstract] [Full Text] [Related]
33. [Biochemical basis for using selective monoamine oxidase inhibitors in the treatment of Parkinson's disease. Critical contribution]. Amato L; Nava L; Rizzo M; Piccoli F Riv Neurol; 1985; 55(1):46-52. PubMed ID: 3927468 [No Abstract] [Full Text] [Related]
34. Role of selegiline in combination therapy of Parkinson's disease. Myllylä VV; Sotaniemi K; Mäki-Ikola O; Rinne UK; Heinonen EH Neurology; 1996 Dec; 47(6 Suppl 3):S200-9. PubMed ID: 8959989 [No Abstract] [Full Text] [Related]
37. [Management of Parkinson's disease in 2009]. Maertens de Noordhout A Rev Med Suisse; 2009 Aug; 5(214):1650-5. PubMed ID: 19772196 [TBL] [Abstract][Full Text] [Related]
38. Malignant syndrome in Parkinson's disease: concept and review of the literature. Mizuno Y; Takubo H; Mizuta E; Kuno S Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S3-9. PubMed ID: 12735909 [TBL] [Abstract][Full Text] [Related]
39. Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa? Okun MS; Weintraub D Mov Disord; 2013 Dec; 28(14):1915-9. PubMed ID: 24243803 [No Abstract] [Full Text] [Related]